FeesSafety
Pluang+

Fidelity National Financial to report Q3 2026 earnings on Nov 5 with webcast and call on Nov 6

Company Fundamentals
05 Oct 2026, 23:15 WIB
PRNewsWire
View Source
Neutral
Fidelity National Financial to report Q3 2026 earnings on Nov 5 with webcast and call on Nov 6

Fidelity National Financial, a leading title insurance and insurance solutions provider, will release its third quarter 2026 earnings after market close on November 5, 2026. The company will hold a webcast and conference call at 11:00 a.m. Eastern Time on November 6 to discuss the results. Investors can access the event via Fidelity's Investor Relations website or by phone. This earnings report will provide insights into the company's financial health and performance in the real estate and insurance sectors.

Fidelity National Financial's upcoming third quarter 2026 earnings release and conference call provide context for readers following this company. For readers following the Financials sector, here is Pluang's market snapshot as of Oct 06, 2026 02:42 WIB: out of 85 priced Financials-sector US stocks tradable on Pluang, 60 rose and 24 fell today. Notable movers include COIN at USD 188.88 with a 1-day change of +3.21%, MSCI at USD 552.75 with +3.13%, and PYPL at USD 54.30 with +2.84%.

More News

DeGen Medical moves to dismiss Carlsmed's patent suit over spinal implant methods.

DeGen Medical moves to dismiss Carlsmed's patent suit over spinal implant methods.

DeGen Medical has filed a motion to dismiss key parts of a patent infringement lawsuit from Carlsmed, which claims DeGen's patient-specific spinal implants infringe on eight patents. DeGen argues that the contested patents cover abstract, computer-im...

Market News
Neutral
1 hour ago
SoFi projects 50% earnings growth in 2027 and no need for new capital raises.

SoFi projects 50% earnings growth in 2027 and no need for new capital raises.

SoFi announced it expects about 50% growth in earnings for 2027, signaling strong financial performance ahead. The company also stated it will not need to raise new capital, indicating confidence in its current funding and business model. This outloo...

Company Fundamentals
Bullish
2 hours ago
China includes Ascentage Pharma's lisaftoclax and renews olverembatinib coverage in 2026 National Reimbursement Drug List

China includes Ascentage Pharma's lisaftoclax and renews olverembatinib coverage in 2026 National Reimbursement Drug List

Ascentage Pharma announced that its cancer drugs lisaftoclax and olverembatinib are now covered by China's 2026 National Reimbursement Drug List (NRDL), effective January 1, 2027. Lisaftoclax is newly included for treating chronic lymphocytic leukemi...

Market News
Bullish
5 hours ago
Jupiter (JUP) price correction halts near key support, signaling potential rebound if it surpasses $0.274.

Jupiter (JUP) price correction halts near key support, signaling potential rebound if it surpasses $0.274.

Jupiter (JUP) trades at $0.263, about 30% below its 12-month high and 92% above its low. The recent price correction stopped near the 200-day moving average at $0.242, a critical support level that buyers defended twice. For a trend reversal, JUP mus...

Technical Signals
Neutral
6 hours ago
Bitcoin drops below 200-week average amid extreme fear and ETF outflows, with no clear cause identified.

Bitcoin drops below 200-week average amid extreme fear and ETF outflows, with no clear cause identified.

Bitcoin recently fell 4.4% below its 200-week moving average, a rare event that coincides with a Fear and Greed Index reading of 10, signaling extreme market fear. Michael Saylor highlighted these metrics but did not link them directly to the price d...

Market News
Bearish
6 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App